Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.
“Over the past nine months, hundreds of millions of people ages 12 and older from around the world have received our COVID-19 vaccine. We are eager to extend the protection afforded by the vaccine to this younger population, subject to regulatory authorization, especially as we track the spread of the Delta variant and the substantial threat it poses to children,” said Pfizer CEO Albert Bourla.
For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press.
- Insane Vid — Man Stream Admission he Killed His Ex-Girlfriend as he prepares to Kill Ex-Wife
- Did Twitter Just Ban Undercover Journalism?
- Inside the January 6th Setup– Who is Ray Epps?
- Campus Crusade for Christ Goes All In On Critical Race Theory
- Not See? Olaf Scholz Becomes German Chancellor, Promises Harsher COVID Response
- Dem Congressman Threatens to Seize Trucks if they Clog DC beltway: ‘Perfect time to impound and give the trucks to small trucking companies’
- Human beings aren’t clownfish
- A Google-Funded ‘Fact Check’ Team is a Handful of Indians With No Experience in Journalism in a Small Town Near Bangladesh.
- Vatican Warns Bishops Against Taking a Stand for Life
- Police: Criminals Are Using New Apple Device To Stalk Victims, Follow Them Home